Related Experiment Video
Updated: Aug 6, 2026
04:46
'Boden Food Plate': Novel Interactive Web-based Method for the Assessment of Dietary Intake
Published on: September 18, 2018
Consumers' experiences and perspectives on reporting adverse drug reactions using digital tools: a qualitative study
Mohammed Gebre Dedefo1, Gizat M Kassie2,3,4, Eyob Alemayehu Gebreyohannes2,5
1Quality Use of Medicines and Pharmacy Research Centre, College of Health, Adelaide University, Adelaide, Australia. mohammed.dedefo@adelaide.edu.au.
International Journal of Clinical Pharmacy
|July 22, 2026
Summary
Consumers are willing to report adverse drug reactions (ADRs) using digital tools, but awareness and usability barriers hinder use. Improving design and accessibility can increase consumer engagement in ADR reporting.
Area of Science:
- Pharmacovigilance
- Digital Health
- Consumer Health Informatics
Background:
- Spontaneous adverse drug reactions (ADRs) are significantly underreported.
- Digital reporting systems offer a potential solution, but consumer adoption barriers are not well understood.
Purpose of the Study:
- To identify facilitators and barriers influencing consumer use of digital tools for ADR reporting.
- To understand consumer expectations and preferences for digital ADR reporting engagement.
Main Methods:
- Qualitative descriptive study using semi-structured interviews with Australian adults who experienced ADRs.
- Inductive thematic analysis of interview data, mapped to the Combined Technology Acceptance Model and Theory of Planned Behaviour (C-TAM-TPB) framework.
Main Results:
- Consumers showed positive intentions for online ADR reporting.
- Facilitators include user-friendly design, layperson language, image use, health record integration, and dual reporting to professionals/regulators.
- Barriers include lack of awareness, registration needs, complex terminology, mandatory fields, and no feedback.
Conclusions:
- Consumers are willing to use digital ADR reporting tools but lack awareness.
- Enhancing usability, user-friendliness, and consumer-specific design can boost engagement.
- Addressing barriers like awareness, registration, jargon, and feedback is crucial for improving pharmacovigilance.
Related Concept Videos
01:19Pharmacovigilance
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
01:26Pharmaceutical Poisoning: Potential Scenarios
Pharmaceutical poisoning can occur through various channels, impacting an estimated 2 million hospitalized patients in the U.S. annually with serious adverse drug responses. These scenarios encompass both therapeutic uses, such as drug toxicity, where even standard dosages can lead to severe central nervous system depression, and non-therapeutic exposures, including accidental ingestion by children, and environmental and occupational exposures.Unintentional poisonings often involve exploratory...
01:24Drug Toxicity: Risk factors
Adverse Drug Reactions (ADRs) are potential complications that arise during pharmacotherapy, influenced by multiple risk factors. Age plays a significant role; both neonates and the elderly are at heightened risk due to their respective immature and diminished metabolic and elimination processes. Gender also impacts ADRs, with females experiencing a 1.5 to 1.7-fold greater risk than males, which may be linked to pharmacokinetic, pharmacodynamic, and hormonal differences. Notably, neonates, the...
01:25Drug Regulation
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
01:29Therapeutic Drug Monitoring: Affecting Factors
Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.
01:20Measurement of Bioavailability: Pharmacodynamic Methods
Pharmacodynamic methods provide insights into a drug's effects on physiological processes over time and play a crucial role in understanding bioavailability and therapeutic efficacy. These methods can be broadly classified into acute pharmacological and therapeutic response approaches, each with distinct mechanisms and applications.The acute pharmacological response method directly correlates a drug's physiological effects, such as ECG or pupil diameter changes, to its time course in the body.